Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Yiviva Signs MOU with AstraZeneca to Develop New Drugs based on TCM Therapies

publication date: Feb 12, 2024

Yiviva, a New York biotech, signed a memorandum of understanding with AstraZeneca China for an R&D collaboration at AstraZeneca’s Innovation Campus (iCampus) in Chengdu, China. The company develops systems biology medicines that treat aging-related diseases based on a combination of traditional Chinese medicine and western technology. Yiviva’s STAR (signal transduction, activity and response) drug discovery platform identifies botanical therapeutics that influence immune function, inflammatory responses, cell growth, metabolic functions and hormone activity. Yiviva has discovered six first-in-class drug candidates to treat cancer and inflammatory diseases. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital